Site Members can sign up for company wide alerts
Lawsuit Overview
September 9, 2013 (Shareholders Foundation) - An investor, who currently hold shares of Hi-Tech Pharmacal Co. (NASDAQ:HITK) , filed a lawsuit in effort to halt the proposed takeover of Hi-Tech Pharmacal Co. by Akorn, Inc.for $43.50 per NASDAQ:HITK share. The plaintiff claims that the defendants breached their fiduciary duties owed NASDAQ:HITK stockholder by agreeing to sell the compa...
You must register (for free) or login to view the entire case.